PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Kim, J.* ; Park, P.J.* ; Machann, J. ; Roden, M.* ; Lee, S.* ; Hwang, J.H.*

Body and liver fat content and adipokines in schizophrenia: A magnetic resonance imaging and spectroscopy study.

Psychopharmacology (Berl.) 234, 1923-1932 (2017)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Although antipsychotic treatment often causes weight gain and lipid abnormalities, quantitative analyses of tissue-specific body fat content and its distribution along with adipokines have not been reported for antipsychotic-treated patients. The purposes of the present study were to quantitatively assess abdominal and liver fat in patients with schizophrenia on antipsychotic treatment and age- and body mass index (BMI)-matched healthy controls and to evaluate their associations with plasma leptin and adiponectin levels. In 13 schizophrenia patients on antipsychotic treatment and 11 age- and BMI-matched controls, we simultaneously quantified visceral and subcutaneous fat content using T1-weighted magnetic resonance imaging and liver fat content by H-1 magnetic resonance spectroscopy. Associations of tissue-specific fat content with plasma levels of leptin and adiponectin were evaluated. Plasma adiponectin level (mu g/mL) was not statistically different between groups (7.02 +/- 2.67 vs. 7.59 +/- 2.92), whereas plasma leptin level (ng/mL) trended to be higher in patients than in controls (11.82 +/- 7.89 vs. 7.93 +/- 5.25). The values of liver fat (%), visceral fat (L), and subcutaneous fat (L) were 9.64 +/- 8.03 vs. 7.07 +/- 7.35, 4.41 +/- 1.64 vs. 3.31 +/- 1.97, and 8.37 +/- 3.34 vs. 7.16 +/- 2.99 in patients vs. controls, respectively. Liver fat content was inversely correlated with adiponectin in controls (r = - 0.87, p < 0.001) but not in patients (r = - 0.26, p = 0.39). In both groups, visceral fat was inversely associated with adiponectin (controls : r = - 0.66, p = 0.03; patients : r = - 0.65, p = 0.02), while subcutaneous fat was positively correlated with leptin (controls : r = 0.90, p < 0.001; patients : r = 0.67, p = 0.01). These findings suggest that antipsychotic treatment may disrupt the physiological relationship between liver fat content and adiponectin but does not essentially affect the associations of adiponectin and leptin with visceral and subcutaneous compartments.
Impact Factor
Scopus SNIP
Altmetric
3.308
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Antipsychotics ; Schizophrenia ; Adiponectin ; Leptin ; Abdominal And Liver Fat ; Mri And Magnetic Resonance Spectroscopy; Adipose-tissue Compartments; Induced Weight-gain; Insulin-resistance; Metabolic Syndrome; Adiponectin Levels; 2nd-generation Antipsychotics; Comparative Metaanalysis; Serum Adiponectin; Leptin Resistance; Visceral Fat
Sprache
Veröffentlichungsjahr 2017
HGF-Berichtsjahr 2017
ISSN (print) / ISBN 0033-3158
e-ISSN 1432-2072
Zeitschrift Psychopharmacology
Quellenangaben Band: 234, Heft: 12, Seiten: 1923-1932 Artikelnummer: , Supplement: ,
Verlag Springer
Verlagsort New York
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes Research and Metabolic Diseases (IDM)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502400-002
DOI 10.1007/s00213-017-4598-5
WOS ID WOS:000402460100012
PubMed ID 28315932
Scopus ID 85015659842
Erfassungsdatum 2017-07-10
[➜Korrektur melden]